135 related articles for article (PubMed ID: 9330414)
21. Effects of budesonide inhalation suspension compared with cromolyn sodium nebulizer solution on health status and caregiver quality of life in childhood asthma.
Murphy KR; Fitzpatrick S; Cruz-Rivera M; Miller CJ; Parasuraman B
Pediatrics; 2003 Sep; 112(3 Pt 1):e212-9. PubMed ID: 12949315
[TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of high-dose inhaled steroids in children with asthma: a comparison of fluticasone propionate with budesonide.
Ferguson AC; Spier S; Manjra A; Versteegh FG; Mark S; Zhang P
J Pediatr; 1999 Apr; 134(4):422-7. PubMed ID: 10190915
[TBL] [Abstract][Full Text] [Related]
23. Growth in asthmatic children treated with fluticasone propionate. Fluticasone Propionate Asthma Study Group.
Allen DB; Bronsky EA; LaForce CF; Nathan RA; Tinkelman DG; Vandewalker ML; Konig P
J Pediatr; 1998 Mar; 132(3 Pt 1):472-7. PubMed ID: 9544904
[TBL] [Abstract][Full Text] [Related]
24. 24 hour and fractionated profiles of adrenocortical activity in asthmatic patients receiving inhaled and intranasal corticosteroids.
Wilson AM; Lipworth BJ
Thorax; 1999 Jan; 54(1):20-6. PubMed ID: 10343626
[TBL] [Abstract][Full Text] [Related]
25. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
Lee DK; Fardon TC; Bates CE; Haggart K; McFarlane LC; Lipworth BJ
Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767
[TBL] [Abstract][Full Text] [Related]
26. Adrenocortical activity with repeated administration of one-daily inhaled fluticasone propionate and budesonide in asthmatic adults.
Wilson AM; Clark DJ; Devlin MM; McFarlane LC; Lipworth BJ
Eur J Clin Pharmacol; 1998 Jan; 53(5):317-20. PubMed ID: 9516029
[TBL] [Abstract][Full Text] [Related]
27. Clinical equivalence of salmeterol/fluticasone propionate in combination (50/100 microg twice daily) when administered via a chlorofluorocarbon-free metered dose inhaler or dry powder inhaler to patients with mild-to-moderate asthma.
Bateman ED; Silins V; Bogolubov M
Respir Med; 2001 Feb; 95(2):136-46. PubMed ID: 11217910
[TBL] [Abstract][Full Text] [Related]
28. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
FitzGerald JM; Boulet LP; Follows RM
Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
[TBL] [Abstract][Full Text] [Related]
29. Comparison of twice-daily inhaled ciclesonide and fluticasone propionate in patients with moderate-to-severe persistent asthma.
Bateman ED; Linnhof AE; Homik L; Freudensprung U; Smau L; Engelstätter R
Pulm Pharmacol Ther; 2008; 21(2):264-75. PubMed ID: 17604664
[TBL] [Abstract][Full Text] [Related]
30. Safety of inhaled fluticasone propionate therapy for pediatric asthma - a systematic review.
Muley P; Shah M; Muley A
Curr Drug Saf; 2013 Jul; 8(3):186-94. PubMed ID: 23859431
[TBL] [Abstract][Full Text] [Related]
31. Effect of addition of salmeterol versus doubling the dose of fluticasone propionate on specific airway resistance in children with asthma.
Murray CS; Custovic A; Lowe LA; Aldington S; Williams M; Beasley R; Woodcock A
Allergy Asthma Proc; 2010; 31(5):415-21. PubMed ID: 20929609
[TBL] [Abstract][Full Text] [Related]
32. A comparison of short-term treatment with inhaled fluticasone propionate and zafirlukast for patients with persistent asthma.
Nathan RA; Bleecker ER; Kalberg C;
Am J Med; 2001 Aug; 111(3):195-202. PubMed ID: 11530030
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled study.
Wasserman RL; Baker JW; Kim KT; Blake KV; Scott CA; Wu W; Faris MA; Crim C
Ann Allergy Asthma Immunol; 2006 Jun; 96(6):808-18. PubMed ID: 16802768
[TBL] [Abstract][Full Text] [Related]
34. Comparison of once- and twice-daily dosing of fluticasone propionate 200 micrograms per day administered by diskus device in patients with asthma treated with or without inhaled corticosteroids.
Wolfe J; Rooklin A; Grady J; Munk ZM; Stevens A; Prillaman B; Duke S; Harding S
J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1153-61. PubMed ID: 10856150
[TBL] [Abstract][Full Text] [Related]
35. The effect of fluticasone propionate on functional status and sleep in children with asthma and on the quality of life of their parents.
Mahajan P; Pearlman D; Okamoto L
J Allergy Clin Immunol; 1998 Jul; 102(1):19-23. PubMed ID: 9679843
[TBL] [Abstract][Full Text] [Related]
36. Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients.
Clark DJ; Lipworth BJ
Thorax; 1997 Jan; 52(1):55-8. PubMed ID: 9039246
[TBL] [Abstract][Full Text] [Related]
37. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
Markham A; Jarvis B
Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
[TBL] [Abstract][Full Text] [Related]
38. Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less.
Barnes NC; Hallett C; Harris TA
Respir Med; 1998 Jan; 92(1):95-104. PubMed ID: 9519232
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of ciclesonide once daily and fluticasone propionate twice daily in children with asthma.
Pedersen S; Engelstätter R; Weber HJ; Hirsch S; Barkai L; Emeryk A; Weber H; Vermeulen J
Pulm Pharmacol Ther; 2009 Jun; 22(3):214-20. PubMed ID: 19141327
[TBL] [Abstract][Full Text] [Related]
40. Body composition and growth in asthmatic children treated with inhaled steroids.
Salvatoni A; Nosetti L; Broggini M; Nespoli L
Ann Allergy Asthma Immunol; 2000 Sep; 85(3):221-6. PubMed ID: 11030277
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
